Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial
Ashwini Budrukkar(Tata Memorial Hospital), Jai Prakash Agarwal(Tata Memorial Hospital), Sheetal Kashid(Homi Bhabha National Institute), Tejpal Gupta(Tata Memorial Hospital), Venkatesh Rangarajan(Tata Memorial Hospital), Monali Swain(Tata Memorial Hospital), Sarbani Ghosh Laskar(Tata Memorial Hospital), Vedang Murthy(Homi Bhabha National Institute), Ritu Raj Upreti(Tata Memorial Hospital), Gouri Pantvaidya(Tata Memorial Hospital), Shrikant Kale(Homi Bhabha National Institute), Sadhana Kannan(Homi Bhabha National Institute), Prathamesh Pai(Tata Memorial Hospital)
International Journal of Radiation Oncology*Biology*Physics
September 2, 2023
Cited by 10
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340